2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Oral Cavity Cancer
Oral cavity cancer, a subtype of head and neck cancer, poses significant challenges in diagnosis and treatment. Research in this field is pivotal in understanding its etiology, progression, and developing effective therapies. Studies focus on identifying risk factors such as tobacco and alcohol use, human papillomavirus (HPV) infection, and genetic predispositions. Advanced imaging techniques aid in early detection, improving prognosis. Additionally, molecular studies unravel the intricate mechanisms driving tumor growth and spread, paving the way for targeted therapies. Immunotherapies, including checkpoint inhibitors, show promise in bolstering the body's immune response against cancer cells. Multidisciplinary approaches integrating surgery, radiation, and chemotherapy continue to evolve, enhancing survival rates and quality of life for patients battling oral cavity cancer. Collaboration between clinicians, researchers, and pharmaceutical industries remains integral in advancing treatment paradigms for this challenging malignancy.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China